• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LUTONIX, INC LUTONIX 035 DRUG COATED PTA DILATATION CATHETER; DRUG COATED PTA BALLOON CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LUTONIX, INC LUTONIX 035 DRUG COATED PTA DILATATION CATHETER; DRUG COATED PTA BALLOON CATHETER Back to Search Results
Model Number 9004
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Thrombosis/Thrombus (4440)
Date of Event 08/19/2022
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported through results of a clinical trial that fifteen days post index procedure using a drug-coated balloon catheter, the subject developed adverse event thrombosed arteriovenous fistula which required prolonged inpatient hospitalization and additional surgical intervention.It was further reported that sixteen days after index procedure, re-intervention of the arteriovenous access circuit was performed on the right arm for access thrombosis.Re-intervention was not successful.Arteriovenous fistula was abandoned permanently due to thrombosis and inability to treat the original treatment area.A new access was created via internal jugular vein for placement of temporary tunneled dialysis catheter type and no target lesion involved.However, the current status of the patient is unknown.
 
Additional Manufacturer Narrative
A manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: the physical device was not returned for evaluation.No photos were provided for review.Therefore, the investigation is inconclusive for the reported failure as no objective evidence was provided for review.A definitive root cause could not be determined based upon the available information.Labeling review: a review of product labeling documentation (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.(expiration date: 06/2024).Device not returned.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LUTONIX 035 DRUG COATED PTA DILATATION CATHETER
Common Device Name
DRUG COATED PTA BALLOON CATHETER
Manufacturer (Section D)
LUTONIX, INC
9409 science center dr
new hope 55428
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury 12804
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key16477718
Report Number3006513822-2023-00010
Device Sequence Number11551062
Product Code ONU
UDI-Device Identifier00801741123214
UDI-Public(01)00801741123214
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
P130024
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Study
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 02/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number9004
Device Catalogue NumberLX351305805F
Device Lot NumberGFFR2033
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 02/06/2023
Initial Report FDA Received Date03/03/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Life Threatening;
Patient Age80 YR
Patient SexMale
Patient Weight73 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-